37 results on '"Morra, Enrica"'
Search Results
2. Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia
3. Clonal architecture ofCXCR4WHIM-like mutations in Waldenström Macroglobulinaemia
4. Post-remission intensive treatment after induction chemotherapy is feasible in selected elderly patients with acute myeloid leukemia and age ≥75 years: A retrospective analysis of the Rete Ematologica Lombarda
5. Autologous stem cell transplantation within vivopurged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma
6. Prognostic relevance of the flow cytometric count of medullar blasts in myelodysplastic syndromes
7. Old and new prognostic factors in acute myeloid leukemia with deranged core-binding factor beta
8. Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop
9. Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia
10. Mutations of CD79A, CD79B and EZH2 genes in immunodeficiency-related non-Hodgkin lymphomas
11. Dasatinib, even at low doses, is an effective second-line therapy for chronic myeloid leukemia patients resistant or intolerant to imatinib. Results from a real life-based Italian multicenter retrospective study on 114 patients
12. Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma
13. Cyclosporine therapy in refractory/relapsed patients with thrombotic thrombocytopenic purpura
14. Interferon alpha-2b as therapy for patients with Ph‘-positive chronic myelogenous leukemia
15. Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes
16. Multiple myeloma associated to HIV infection: report of two patients
17. Bone marrow and blood involvement by non-Hodgkin's lymphoma: A study of clinicopathologic correlations and prognostic significance in relationship to the Working Formulation
18. Molecular characterization of post‐transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients
19. DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients
20. Analysis of immunoglobulin heavy and light chain variable genes in post‐transplant lymphoproliferative disorders
21. Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders
22. Incidence of novel N-glycosylation sites in the B-cell receptor of lymphomas associated with immunodeficiency
23. Frequent aberrant promoter hypermethylation of O6‐methylguanine‐DNA methyltransferase and death‐associated protein kinase genes in immunodeficiency‐related lymphomas
24. E2A-PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical features
25. Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia
26. Effective treatment of autoimmune hemolytic anemia and hairy cell leukemia with interferon-alpha
27. Invasive aspergillosis in haematological malignancies: Clinical findings and management for intensive chemotherapy completion
28. Fludarabine, cytarabine, and granulocyte-colony stimulating factor for the treatment of high risk myelodysplastic syndromes
29. Hepato-splenic ?? T-cell lymphoma: A rare entity mimicking the hemophagocytic syndrome
30. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-hodgkin's lymphoma
31. Anaplastic large cell (CD30/Ki-1+) lymphoma in HIV+ patients: clinical and pathological findings in a group of ten patients
32. The role of systemic high-dose cytarabine in the treatment of central nervous system leukemia clinical results in 46 patients
33. RESIDUAL MEDIASTINAL WIDENING FOLLOWING THERAPY IN HODGKIN'S DISEASE
34. Hematologic and clinical features of patients with chromosome 5 monosomy or deletion (5q)
35. Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease.
36. Limited feasibility of double transplant in multiple myeloma: results of a multicenter study on 153 patients aged <65 years.
37. Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.